CXCL9 and neoplasm: showed that the lapatinib and doxorubicin enhanced the expression of Stat1‐dependent endogenous chemokines CXCL9, CXCL10, and CXCL11 (importance for attracting CD8+ T cells), and reduced tumor‐associated macrophages (TAMs), consequently augmenting the antitumor immune response 104.